Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Azithromycin With or Without Amoxicillin to Prevent Peripartum Infection and Sepsis
NCT03248297Phase 4Completed
- Sponsor
- University of Alabama at Birmingham
- Start
- Jan 2018
- Primary completion
- May 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of azithromycin in postpartum sepsis, postpartum endometritis and postpartum fever (3 arms), sponsored by University of Alabama at Birmingham. Primary endpoint: Number of Participants Who Experienced Composite Peripartum Infection or Death at 6 weeks. Started Jan 2018; status: completed.
02
Drugs
azithromycin
03
Conditions
postpartum sepsispostpartum endometritispostpartum fever
Beyond the preview
Go deeper on NCT03248297.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03248297.